Author:
Navaneethan Sankar D,Nigwekar Sagar U,Sehgal Ashwini R,Strippoli Giovanni FM
Reference51 articles.
1. Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease;Bianchi;Kidney International,2006
2. Spironolactone reduces proteinuria and retards the progression of kidney disease: a long-term study [Abstract];Bianchi;Journal of the American Society of Nephrology,2006
3. A double blind, placebo controlled study on the effect of the aldosterone receptor blocker: spironolactone, in patients with persistent proteinuria on longterm ACE inhibitor therapy, with or without an ATRB [Abstract];Chrysostomou;Nephrology,2005
4. Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker;Chrysostomou;Clinical Journal of the American Society of Nephrology: CJASN,2006
5. Antiproteinuric efficacy of eplerenone, enalapril, and eplerenone/enalapril combination therapy in diabetic hypertensives with microalbuminuria [abstract];Epstein;American Journal of Hypertension,2002
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献